a, Tail suspension test (TST) was performed in male Mnk1/2 -/-mice (n=9) and their wildtype littermates (n=9). b, TST was also performed in male Eif4e +/+ (n=6) and ki/ki mice (n=7). c, Male Mnk1/2 +/+ and -/-mice locomotor activity in an open field (OF) was measured in two sessions 7 days apart from each other (data from 1 st session is also presented in Fig. 1i ) (n=13 Mnk1/2 +/+, n=8 Mnk1/2 -/-). d, Time of exploration of the OF center was recorded at the same time in the male mice (data from 1 st session is also presented in Fig. 1g ). e, Locomotor activity in the OF for female wildtype and Mnk1/2 -/-mice was measured in two sessions 7 days apart (data from the 1 st session is also presented in Fig. 1i ) (n=7 Mnk1/2 +/+, n=14 Mnk1/2 -/-). f, Time of exploration of the OF center was recorded at the same time (data from 1 st session is also presented in Fig. 1g ). * p<0.05, *** p<0.001 vs. wildtype mice (see Supplementary Table 2 for detailed results of statistical tests).
Supplementary Figure 6
Supplementary Figure 6. Elevated TNF and signs of neuroinflammation in Mnk1/2 -/-and Eif4e ki/ki mice. a, Eotaxin levels in the PFC of Mnk1/2 -/-and Eif4e ki/ki mice and their respective littermate control mice (n=9 Mnk1/2 +/+, n=9 Mnk1/2 -/-; n=11 Eif4e +/+; n= 10 Eif4e ki/ki). b, Eotaxin was also measured in the peripheral blood of Mnk1/2 -/-and Eif4e ki/ki mice (n=7 Mnk1/2 +/+, n=13 Mnk1/2 -/-; n=7 Eif4e +/+; n=10 Eif4e ki/ki). c, TNF levels in the PFC of Mnk1/2 -/-and wildtype mice (n=7 Mnk1/2 +/+, n=8 Mnk1/2 -/-). d, TNF levels in the peripheral blood of Mnk1/2 -/-and wildtype mice (n=6 Mnk1/2 +/+, n=12 Mnk1/2 -/-). e, TNF levels in the peripheral blood of Eif4e ki/ki and wildtype mice (n=5 Eif4e +/+; n=13 Eif4e ki/ki). f, Soluble TNF receptor 1 (sTNFR1) levels in the circulation of Eif4e ki/ki and wildtype mice (n=7 Eif4e +/+; n=9 Eif4e ki/ki).g, Steady-state mRNA levels of the microglial activation marker Iba1 (Aif1) in the hippocampus of wildtype and Eif4e ki/ki mice (n=5 Eif4e +/+; n=8 Eif4e ki/ki). h, Number of Iba1 positive cells per 0.01 mm 2 of hippocampus from wildtype and Eif4e ki/ki mice treated with saline or LPS (IP, 2.5 mg/kg, IP) 48 h before tissue collection (n=4/group). h, Representative images of immunestaining for Iba1 in the hippocampus of wildtype or Eif4e ki/ki mice. * p<0.05, **p<0.01 vs wildtype (see Supplementary Table 2 for detailed results of statistical tests).
Supplementary Figure 7
Supplementary Figure 7. Inhibition of TNF reverses depression-like behavior in Mnk1/2 -/-mice. a, Effect of chronic administration of saline or dominant negative TNF (DN TNF, ICV) in wildtype and Mnk1/2 -/-mice in the FST (n=9 Mnk1/2 +/+ Saline, n=10 Mnk1/2 +/+ DN TNF, n=6 Mnk1/2 -/-Saline, n=8 Mnk1/2 -/-DN TNF). b, These mice were also evaluated in the novelty suppressed feeding (NSF) task (n=8 Mnk1/2 +/+ Saline, n=10 Mnk1/2 +/+ DN TNF, n=8 Mnk1/2 -/-Saline, n=10 Mnk1/2 -/-DN TNF). c, Home-cage feeding (HCF) was also determined in wildtype and Mnk1/2 -/-mice. ** p<0.01 vs. wildtype; && p<0.01 vs. Mnk1/2 -/-treated with saline (see Supplementary Table 2 for detailed results of statistical tests). In a control state, eIF4E phosphorylation stimulates Nfkbia translation, which contributes to the baseline repression of the NF-B complexes and thus keeps the levels of transcription of Tnf inhibited. In the absence of Mnk1/2 or by mutating the unique phosphorylation site in eIF4E, translation of Nfkbia is decreased, leading to increased activity of the NF-B complex and increased levels of Tnf translation. Increased TNFa produces serotonergic dysfunction and depression-and anxiety-like behaviors. Supplementary Table 1 GAPDH:
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